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ABSTRACT
Background
Ames dwarf mice demonstrate delayed aging processes in multiple body systems.
We compared muscle composition and area between dwarf and wild-type mice to
determine if any significant differences exist.
Methods.
We resected soleus, gastrocnemius/plantaris, tibialis anterior, and extensor
digitorum longus muscles from both dwarf and wild-type mice, then froze, sliced, set on
slides, and stained to isolate fast-twitch and slow-twitch fibers. Microscopy images were
taken at 10x magnification and fiber composition and cross-sectional area were measured
in soleus muscles.
Results
Wild-type mice had an average composition of 52.3% fast-twitch and 47.7% slowtwitch fibers while dwarf mice had 66.3% slow-twitch and 33.7% fast-twitch fibers.
Differences between fast- and slow-twitch composition of dwarfs and fast-twitch and
slow-twitch composition of 12-month-old wild-type versus dwarfs all yielded statistical
significance. Dwarf mice had a smaller cross-sectional area than both 3-month and 12month wild-type mice. Both comparisons were significant at p<0.0001.
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Conclusion
Dwarfs demonstrated smaller muscle fiber area than wild-type mice, which was not
surprising as dwarf mice have an innately slighter stature than wild-types. Wild-type
mice, with a higher ratio of fast-twitch fibers, would exhibit higher rates of myosin
ATPase hydrolysis and muscular strength, while dwarf mice, with more slow-twitch
fibers, would display greater oxidative capacity and muscular endurance in the soleus
muscle.
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CHAPTER I

LITERATURE REVIEW
Sarcopenia translates from the Greek words “sarco-“, meaning “flesh”, and “penia”, meaning “deficiency.” Cruz-Jentoft et al1 give: “Sarcopenia is a syndrome
characterised by progressive and generalised loss of skeletal muscle mass and strength
with a risk of adverse outcomes such as physical disability, poor quality of life and
death.” There are no known certain causes of sarcopenia, but there are many theories,
including chemical, mechanical, and nervous system changes. Baumgartner et al²
suggest tissue secretion changes, decreased responsiveness to trophic hormones, diet and
metabolism changes, disuse atrophy or selective atrophy of type II fibers which contract
and relax more quickly and allow greater generation of force than type I fibers, and
decreased innervation and blood supply may play a role in age-related muscle loss.
Although it is commonly accepted that muscle mass decreases with age, the rate of
decline is unknown. Vandervoort and McComas³ tested ankle musculature strength in
young, middle aged, and elderly men and women and found that plantarflexor and
dorsiflexor strength, specifically, began to decrease around the 6th decade of life and then
declined at a rate of 1.3% per year. Rantanen et al4 found a 1% per year decrease in grip
strength in Japanese-American males over a 27-year period; initial ages ranged from 45
to 68 years old. A steeper decline in strength (i.e. greater than 1.5% per year) was
1

positively correlated with older baseline age, greater weight decrease over the follow-up
period, and presence of comorbidities such as stroke, diabetes, chronic obstructive
pulmonary disease (COPD), or heart disease. Doherty5 examined numerous studies and
calculated an average of 20% to 40% less overall strength for healthy individuals in the
7th and 8th decades of life versus younger adults. The difference increased to 50% for
those in their 9th decade and older. Kallman et al6 used grip strength and estimated
muscle mass of individuals between the ages of 20 and 100 to determine loss of strength
from both a longitudinal and cross-sectional view. They found that, on average, both
variables peaked in the 4th decade (much earlier than the findings of Vandervoort and
McComas) and then began to decline thereafter. Over the 9 year follow-up period,
however, 48% of individuals under age 40, 29% between 40 and 59 years old, and 15%
aged 60 and older did not show any decrease in grip strength. The decreasing percentage
of individuals without loss of strength as age increases could support the idea of
increased presence of sarcopenia with increased age.
The results of Gallagher et al7 support this idea of strength loss with age. They
found a significant decrease in total appendicular skeletal muscle in both men and women
after a follow-up of an average 4.7 years. However, in men, body weight showed no
significant change while fat mass significantly increased. Both body weight and fat mass
decreased in women, but was not significant. Weight loss is often used as a measure of
sarcopenia in the elderly, but this study suggests that this may not be a reliable means.
As physical therapists, our primary concern for all patients is functional ability.
Theoretically, the loss of muscle mass would lead to loss of muscle strength and decline
2

of function. Cress and Meyer8 evaluated peak oxygen consumption (Vo2peak) and
isokinetic knee extensor torque (KET) values for men and women ages 65 to 97 and
compared it to their physical function using the Continuous-Scale Physical Function
Performance test (CS-PFP) which scores 16 different household tasks with various units
of measurement (time, distance, etc) to determine level of function. They then analyzed
whether their scores could predict independent living. Two groups lived independently,
either as community-dwellers or in a congregate care facility with little to no functional
limitation, and the dependent group lived in a congregate care facility with significant
functional limitation. They found that the “threshold” values for Vo2peak (20 mL/kg/min)
and KET (2.5 N·m/[kg/m]) correlated with a CS-PFP score of 57 units (maximum score =
100 units). All participants with CS-PFP scores above 57 lived independently, while
only 57% of participants with scores under 57 lived independently. According to
ElderCare,9 the cost of an assisted living facility ranges from $25,000 to $50,000 a year.
Medicare does not provide any financial assistance, though Medicaid may pay part of the
cost of services in some states. Prevention and treatment of individuals with sarcopenia
may prevent this financial burden on patients and their families. For instance, physical
therapy treatment for strengthening, endurance, and balance 2 times per week for 4 weeks
twice a year would cost approximately $1,060. If this is able to be covered by insurance,
this could reduce costs to the patient as well as Medicare.
Lauretani et al10 compared differences in isometric muscle strength, calf crosssectional area, walking ability, and walking speed in 1,030 individuals between the ages
of 20 and 102 to determine prevalence of sarcopenia. Presence was defined as a score of
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2 standard deviations below the average value for the 20 to 29 year old age group of the
same gender. Strength and muscle mass were further analyzed as potential predictors of
mobility limitations. They found that muscle strength declined considerably with age and
was strongly associated with factors of poor mobility (walking ability and speed).
Muscle mass (calf cross-sectional area), however, declined much less rapidly than
strength and was not consistently associated with mobility limitations. Based on their
findings, the authors suggest that loss of muscle strength should be considered in
conjunction with loss of muscle mass when defining sarcopenia. Janssen et al11
compared muscle mass to functional impairments in older adults. They measured muscle
mass using bioimpedance, a living organism or tissue’s response to electrical current, and
expressed it as skeletal muscle mass index or SMI (skeletal muscle mass/body mass x
100). Class I sarcopenia was defined as an SMI between 1 standard deviation above and
2 standard deviations below the average score for individuals between 18 and 39 years
old of the same sex; class II sarcopenia was a score greater than 2 standard deviations
below the reference average. The authors found that the likelihood of functional
impairment was 2 to 3 times more for older men and women with class II sarcopenia than
for similar-aged individuals with a normal SMI. They also reported an increase in both
classes of sarcopenia from the 3rd to 6th decades of life with no increase afterward. This
is in agreement with the previously discussed findings of Kallman et al,6 but conflicts
with Vandervoort and McComas,3 who found that loss of muscle strength, sarcopenia,
did not begin until the 6th decade and then further declined. This may suggest that newer
research (studies conducted in 2002 and 1986, respectively) has found that onset of
sarcopenia occurs earlier than previously thought. Therefore, sarcopenia intervention
4

could be beneficial during early to middle adulthood to prevent or slow the decline of
muscle mass and strength and to maintain function.
Age is not the only predictive factor for sarcopenia being researched. Ogawa et
al12 studied the correlation of extracellular heat shock protein (eHsp72) with age in 665
men and women. In general, Hsps act as a “molecular chaperone” to protect cell
proteomes by recognizing damaged proteins and directing them to either a repair or
proteolytic pathway. These Hsps degenerate with age due to time and decreased
resistance of oxidants in the body. Protection of motor neurons in particular is associated
with eHsp72 so, hypothetically, degradation of this protein could lead to decreased
protection of neurological muscle function and decreased muscle mass. They found that
higher plasma eHsp72 levels were significantly positively correlated with decreased
muscle mass, grip strength, and walking speed. These findings indicate that eHsp72 may
potentially be used as a biomarker for sarcopenia in the elderly population. Visser et al13
found that, based on both grip strength and skeletal muscle mass, low levels of 25hydroxyvitamin D (25-OHD) and high levels of parathyroid hormone (PTH) were
associated with higher risk of sarcopenia in both men and women over the age of 65. The
authors defined sarcopenia as being in the lowest 15th percentile of the sex-specific
cohort; equal to a 40% or greater loss in grip strength and a 3% or greater loss in muscle
mass. The more that is known about the significant risk factors for sarcopenia, the
greater the chances of early detection and prevention of functional limitations or
disability due to weakness.

5

The Ames dwarf mice, which exhibit increased longevity and delayed aging
compared to their wild-type counterparts, lack growth hormone (GH), prolactin (PRL),
and thyroid-stimulating hormone (TSH). Bartke and Brown-Borg14 suggest that the
absence of GH in these mice reduces the synthesis of insulin-like growth factor 1,
secretion of insulin, plasma glucose levels, production of reactive oxygen species, and
oxidative damage while increasing glucose sensitivity of the liver, antioxidant defenses,
and resistance to oxidative stress. We decided to use the Ames dwarf mouse to assess
any difference in fiber size and the composition of fast twitch (type II) versus slow twitch
(type I) muscle fibers due to these hormonal differences and their apparent resistance to
the typical aging processes in other body systems.
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CHAPTER II

METHODS
The surgical procedure to collect the hindlimb muscles of the mice was performed
with the animals under anesthesia. We used 100 μL/10g body weight of 2.5%
tribromoethanol in 0.9% saline solution utilizing an intraperitoneal injection. Adequate
sedation was determined by checking pain reflexes: squeezing feet and eliciting corneal
reflex. The first incisions were made around the leg at the ankles to release the skin and a
slit was made proximally to allow us to peel the skin up to the hip. The heel cord was cut
to free the insertion of the gastrocnemius, plantaris, and soleus. The soleus was then
separated and removed from the gastroc/plantaris. Then the gastroc/plantaris complex
was removed from its attachment at the knee. The tibialis anterior (TA) was separated
from the tibia, then freed from the ankle and the proximal leg. Finally, the extensor
digitorum longus (EDL) was cut at the ankle and the knee. All muscles were weighed
and measured, placed on a piece of liver from a wild-type mouse, covered with optimal
cutting temperature (OCT) compound, and frozen in isopentane in liquid nitrogen. The
muscles were stored in liquid nitrogen at -80˚C until we were ready for slicing.
We used a Cryostat at -25˚C for slicing the muscle tissue. The blade was first
cleaned with alcohol then allowed to cool in the Cryostat for 30 minutes. The tissue
7

samples were also kept in the Cryostat to increase their temperature to -25˚C. The tissues
were then mounted with OCT vertically onto the chuck, trimmed in 50μm sections until
muscle tissue was seen, and then further trimmed in 10μm sections for 50 slices.
Collection of slices began at this point with 30 consecutive sections (3 sections per slide),
50 sections discarded, etc. until the end of the bulk of each muscle was reached. The
slides used were Fisherbrand Superfrost Plus Microscope slides (Thermo Fisher
Scientific, Waltham, MA). Slides containing tissue samples were stored at -20˚C.
Following collection of the tissue samples, slides were stained with hematoxylin
and eosin for measurement of cross-sectional area. The slides were removed from the
freezer and allowed to dry. They were set in Harris hematoxylin for 2 minutes, then
rinsed twice in distilled water. We dipped them 3 times in acid alcohol (11 mL glacial
acetic acid, 95 mL ethanol, 5 mL distilled water), rinsed them in distilled water, dipped
them 6 times in ammonium water (0.625 mL 25% ammonium hydroxide, 250 mL
distilled water), followed by another rinse in distilled water. The slides were then put in
the working eosin solution (62.5 mL stock eosin, 187.5 mL 80% ethanol, 1.56 mL glacial
acetic acid) for 30 seconds, rinsed in distilled water twice, and dehydrated in ethanol at
70%, 95%, and 100% for 15 seconds each. Each slide was cleared in xylene and
mounted with a slipcover in Permount. The newly mounted slides were stored at room
temperature.
Tissue samples used for comparison of fast versus slow twitch fibers were stained
for myosin heavy chains. Slides were brought to room temperature and a PAP pen was
used to encircle the tissues. One slide was used as a control. All slides were rinsed in 1X
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Phosphate Buffered Saline (PBS) for 2 minutes then laid into a Pyrex® dish. H2O2/horse
serum was added to slides for 5 minutes, then rinsed in PBS twice for 2 minutes.
We used the Avidin/Biotin Blocking Kit15 (Vector Labs, Burlingame, CA) to
block avitin binding sites and biotin receptors from staining; the Mouse on Mouse
(M.O.M.) Peroxidase Kit16 (Vector Labs, Burlingame, CA) to isolate specific proteins
(fast twitch and slow twitch antibodies), improve distinction between primary and
secondary proteins and antibodies to reduce background staining, and reduce unwanted
binding of secondary antibodies to mouse tissue immunoglobulin; and the DAB
Peroxidase Substrate Kit17 (3,3’-diaminobenzidine) to produce a visible reaction with the
isolated antibodies.
The slides were set with avidin blocking solution and biotin blocking solution for
15 minutes each with a 2 minute PBS rinse between and after the solutions. Then, they
were incubated in IgG blocking reagent in a covered, humid Pyrex® dish for 1 hour. All
slides were rinsed in PBS for 2 minutes before incubating in protein concentrate for 5
minutes. Slides were then separated into 2 groups for fast and slow twitch stains: MOM
diluents + slow antibody and MOM diluents + fast antibody. The control slide did not
receive any antibody stain. The groups were incubated in their respective primary
antibody dilutions for 30 minutes then rinsed twice in PBS for 2 minutes. All slides
(including control) were incubated in MOM Biotinylated Anti-Mouse IgG Reagent for 10
minutes. Two PBS rinses for 2 minutes each were performed, then the slides were
incubated in Reagent A+B mix for 5 minutes after the mix was allowed to set for 30
minutes. Slides received 2 more 2-minute PBS rinses then incubated in DAB solution for
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10 minutes. Finally, all slides were rinsed in distilled water for 1 minute, dehydrated in
alcohol for 2 dips each in 70%, 95%, and 100%, and dehydrated in xylene. Coverslips
were applied, using a Permount solution, and laid flat overnight to dry. Slides were
stored at room temperature after drying.

10

CHAPTER III

RESULTS
Microscopy (10x) images of well-sliced, -mounted, and –stained slides were
obtained for analysis. We compared counts of stained and unstained cells for fast twitch
and slow twitch stained slides between the following: 3- vs. 12-month-old wild-type
mice, 3- vs. 12-month-old dwarf mice, 3-month-old wild-type vs. dwarf mice, and 12month-old wild-type vs. dwarf mice. Due to human error, lack of researcher experience,
and the large amount of variability in the cutting, mounting, and staining of each tissue
slice, total cell counts varied between images from the same tissue. Some cells could
have been stained more than once or not at all and the borders of many cells were not
well-defined. We decided to convert all the cell counts to percentages for a more logical
comparison. Fast twitch-stained left soleus muscle slices of a 3-month-old wild-type
mouse contained 48.5% stained (fast twitch) and 51.5% unstained cells; slow twitchstained slices from the same tissue contained 45.6% unstained and 54.4% stained (slow
twitch) cells. Fast twitch-stained right soleus muscle slices of a 12-month-old wild-type
mouse had 62.2% stained (fast twitch) and 37.8% unstained cells; slow twitch-stained
slices showed 52.8% unstained and 47.2% stained (slow twitch) cells, a considerable
difference between staining conditions. Fast twitch-stained soleus muscle slices of two
dwarf mice yielded 31.3% and 35.5% stained (fast twitch) and 68.7% and 64.5%
11

unstained cells; slow twitch-stained slices of the same muscles had 36.5% and 31.5%
unstained and 63.5% and 68.5% stained (slow twitch) cells. The results are outlined in
Table 1. Independent of age, wild-type mice had a higher percentage of fast twitch
muscle cells than dwarf mice and dwarf mice had a greater percentage of slow twitch
cells than wild-type mice.
We used Scion Image to measure the cross-sectional areas of muscle fibers of a 3month wild-type mouse soleus, 12-month wild-type mouse soleus, and 6-month dwarf
mouse soleus. Unpaired t-test comparison using QuickCalcs online software18 between
wild-type mice revealed a slightly greater cross-sectional area in the 3-month samples
versus 12-month samples, but this was not significant. The 6-month dwarf samples had a
significantly smaller area than both ages of the wild-type mice. Detailed results are
available in Table 2.
Two-sample t-tests were used to compare fast-twitch versus slow-twitch cell
percentage in 3-month-old wild-type, 12-month-old wild-type, and 6-month-old dwarf
mice with SISA online software.19 Statistically significant differences were found
between fast and slow-twitch fiber composition of both dwarf samples, fast-twitch fiber
percentage between 12-month-old wild-type and both dwarf samples, and slow-twitch
fiber percentage between 12-month-old wild-type and one dwarf sample. Table 3
outlines full statistical analysis of all comparisons.
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Table 1. Fast twitch versus slow twitch fiber composition comparison in dwarf and wildtype mice
stained
unstained
total
% stained
% unstained
stained
unstained
total
% stained
% unstained

3 fast L sol n2
231
245

3 slow L sol n2
249
209

12 fast R sol n4
181
110

12 slow R sol n4
153
171

476

458

291

324

0.485
0.515

0.544
0.456

0.622
0.378

0.472
0.528

Fast sol d1
109
239

Slow sol d1
235
135

Fast sol d2
194
352

Slow sol d2
387
178

348

370

546

565

0.313
0.687

0.635
0.365

0.355
0.645

0.685
0.315

Table 2. Cross-Sectional area comparison of soleus muscles of dwarf and wild-type mice
Age, Muscle, Mouse Type
3 H&E L Sol N2
12 H&E R Sol N4
6 H&E Sol D1
2471.01
2246
808.43
2665.32
2181
778.29
2087.57
3484
484.23
2238.25
3415
457.21
3387.5
1695
659.84
3598.44
1621
653.6
2339.04
1357
871.81
2344.23
1347
841.68
2519.84
3386
814.66
2744.29
3307
788.69
Average Cell Area (μm2)

2639.55

2403.9
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715.84

Table 3. Statistical analysis summary
Cross-Sectional
Area
3mo N
M
2639.55
SD
491.77
SEM
155.51
N
10

P value
Mean Difference
95% CI
t value
df
SED

12mo N
2403.9
905.06
286.2
10

6mo D
715.84
147.29
46.58
10

3mo N vs
12mo N
0.4787
235.65
-448.67 to
919.97
0.72
18
325.73

3mo N vs
6mo D
<0.0001*
1923.71
1582.65 to
2264.77
11.85
18
162.34

12mo N vs
6mo D
<0.0001*
1688.06
1078.85 to
2297.26
5.82
18
289.97

3mo
F vs S
0.5608
F
3 vs 12mo
0.193
S
3 vs 12mo
0.4752

12mo
F vs S
0.1516
F
3mo vs d1
0.0542
S
3mo vs d1
0.402

d1
F vs S
0.001*
F
12mo. vs d1
0.0014*
S
12mo vs d1
0.1214

Cell Count
P value
P value
P value

d2
F vs S
0.0012*
F
3mo vs d2
0.1562
S
3mo vs d2
0.2036

F
12mo. vs d2
0.007*
S
12mo vs d2
0.0478*

M = mean, SD = standard deviation, SEM = standard error of the mean, N = sample size,
P = probability, CI = confidence interval, t = mean difference relative to its standard
deviation, df = degrees of freedom, SED = standard error of difference between two
means, an asterisk (*) denotes a statistically significant finding at p<0.05
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CHAPTER IV

DISCUSSION
The 3-month-old and 12-month-old wild-type mice had almost opposite
percentages of muscle cell types, which correlates with the decrease in fast-twitch muscle
fibers seen in humans as they age.20 We were unable to obtain viable images for 3-month
and 12-month dwarf mice for comparison, so we cannot determine any changes in muscle
composition with age. This would have allowed us to compare rates of change of fasttwitch and slow-twitch fiber composition between wild-type and dwarf mice to provide
evidence of a “slowed” aging process in the musculoskeletal system of dwarves.
Area difference between dwarf and normal mice was unsurprising as dwarfs are
inherently smaller than normal wild-type mice. Again, images of 3-month and 12-month
dwarves were unable to be obtained, so we cannot make any conclusions regarding
changes in fiber size as age increases.
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CHAPTER V

CONCLUSION
Dwarf mice had a higher percentage of slow twitch muscle fibers, a lower
percentage of fast twitch fibers, and a smaller average cross-sectional area than wild-type
mice of both ages. Based on muscle composition, wild-type mice have greater strength
and increased myosin ATPase hydrolysis, while dwarf mice have higher endurance and
greater oxidative capacity. This may be due to a number of factors and more research
will need to be done to determine causation. An inherently greater composition of slowtwitch muscle fibers could possibly delay the aging process in dwarf mice as there are
fewer fast-twitch fibers in which degeneration may occur. Dwarfs are naturally smaller
than wild-type mice, but because we were unable to make a comparison among dwarf
mice of different ages, we cannot examine differences between dwarfs and normal mice
of the same age.
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